Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

GRAL

GRAIL Inc

May 06 • 04:00PM ET

62.75

+8.35 15.35 %

Healthcare • Diagnostics & Research • USA • Mid • NASD

May 06, 4:28 AMGRAIL beats Q1 2026 estimates with revenue $40.8M (+28% YoY) as Galleri growth supports reiterated 2026 guidance ahead of ASCO, FDA milestones

Peers: ILMN EXAS GH PACB TXG QGEN CRSP EDIT CDNA FULC

| Held by: XBI VTI IWM VXF IWN IBB VTWO SCHA DFAS PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-10.38	Insider Own	9.26%	Shs Outstand	41.13M	Perf Week	26.28%
Market Cap	2.57B	Forward P/E	-	EPS next Y	-10.90	Insider Trans	-26.79%	Shs Float	37.22M	Perf Month	27.67%
Enterprise Value	1.80B	PEG	-	EPS next Q	-2.75	Inst Own	73.72%	Short Float	18.78%	Perf Quarter	-36.54%
Income	-395.32M	P/S	16.49	EPS this Y	3.47%	Inst Trans	10.02%	Short Ratio	5.57	Perf Half Y	-30.13%
Sales	156.12M	P/B	1.03	EPS next Y	-1.61%	ROA	-13.99%	Short Interest	6.99M	Perf YTD	-26.69%
Book/sh	60.79	P/C	3.13	EPS next 5Y	2.48%	ROE	-16.09%	52W High	118.84 -47.20%	Perf Year	95.12%
Cash/sh	20.07	P/FCF	-	EPS past 3/5Y	60.02% -41.05%	ROIC	-15.55%	52W Low	29.95 109.52%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	38.37% -	Gross Margin	-44.01%	Volatility	8.60% 7.01%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.54	EPS Y/Y TTM	82.94%	Oper. Margin	-330.72%	ATR (14)	4.02	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.51	Sales Y/Y TTM	19.44%	Profit Margin	-253.22%	RSI (14)	64.14	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.74	EPS Q/Q	25.94%	SMA20	20.57%	Beta	3.04	Target Price	66.86
Payout	-	Debt/Eq	0.02	Sales Q/Q	28.11%	SMA50	23.33%	Rel Volume	1.01	Prev Close	54.40
Employees	910	LT Debt/Eq	0.02	Earnings	May 05 AMC	SMA200	-6.50%	Avg Volume	1.26M	Price	62.75
IPO	Jun 12, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.12% 4.16%	Trades		Volume	1,257,425	Change	15.35%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-26	Initiated	Mizuho	Neutral	$58
Mar-18-26	Upgrade	TD Cowen	Hold → Buy	$65
Feb-19-26	Initiated	TD Cowen	Hold	$114
Feb-17-26	Initiated	Robert W. Baird	Outperform	$113
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight	$110
Nov-12-25	Upgrade	Guggenheim	Neutral → Buy	$100
Apr-21-25	Initiated	Canaccord Genuity	Buy	$32
Nov-27-24	Initiated	Morgan Stanley	Equal-Weight	$16
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Oct-17-24	Initiated	Guggenheim	Neutral

May-05-26 04:01PM	GRAIL Reports First Quarter 2026 Financial Results (PR Newswire) +15.35%
Apr-30-26 04:01PM	GRAIL to Present at the BofA Securities 2026 Health Care Conference (PR Newswire) +9.64%
Apr-22-26 04:01PM	GRAIL to Announce First Quarter 2026 Financial Results (PR Newswire)
Apr-21-26 04:53PM	GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting (PR Newswire)
Apr-07-26 04:01PM	GRAIL Announces Integration of the Galleri Test into Epic Electronic Health Record Platform to Expand Access Nationwide (PR Newswire) -5.01%
01:09PM	Loading…
Apr-01-26 01:09PM	Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection (PR Newswire)
Mar-18-26 09:34AM	Block upgraded, Starbucks downgraded: Wall Street's top analyst calls (The Fly)
09:00AM	LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED (PR Newswire)
Mar-12-26 04:30PM	GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor (PR Newswire)
Mar-02-26 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-27-26 12:19AM	Here's What Analysts Are Saying About Grail Inc. (GRAL) (Insider Monkey) -8.38%
Feb-26-26 05:00PM	Grail's Stock Dropped 50% on Friday. Investors Still Have High Hopes for the Biotech. (Barrons.com) +12.18%
Feb-24-26 04:02PM	GRAIL to Present at the TD Cowen 46th Annual Health Care Conference (PR Newswire) +17.01%
02:24PM	Lost Money on GRAIL, Inc. (GRAL)? Possible Fraud - Contact Levi & Korsinsky Today (Newsfile)
Feb-23-26 09:29AM	GRAIL Stock Tumbles - National Health Service Galleri Trial To Blame (Benzinga) -14.30%
05:01PM	Loading…
Feb-20-26 05:01PM	Grail Shares Crashes 50% After Major Cancer Screening Trial Fails Main Goal (GuruFocus.com) -50.55%
04:33PM	Stocks Settle Higher as SCOTUS Rejects President Trumps Tariffs (Barchart)
04:28PM	Stock Market Today: Nasdaq Charges Higher As Trump Announces Global Tariff; Nvidia Shares Rise (Live Coverage) (Investor's Business Daily)
04:26PM	This once-hot cancer-detection company's stock got cut in half after a failed trial (MarketWatch)
01:16PM	Why Grail Stock Has Plunged 50% Despite Earnings Beat (Barrons.com)
11:27AM	Stock Market Today: Dow Turns Higher As Supreme Court Nixes Trump Tariffs (Live Coverage) (Investor's Business Daily)
11:25AM	Stocks Rebound as Supreme Court Strikes Down President Trumps Tariffs (Barchart)
11:02AM	Supreme Court Rules Against Trump's Tariffs: These 10 Stocks Are Soaring (Benzinga)
10:34AM	Biotech Stock Plummets on Cancer Screening Trial Results (Schaeffer's Research)
09:48AM	Stock Market Today: Dow Falls On Inflation Data, Weak GDP; Trump Tariff Ruling May Be Up Next (Live Coverage) (Investor's Business Daily)
09:44AM	Grail Stock Tanks After Cancer-Screening Study (The Wall Street Journal)
08:15AM	Stock Market Today: Dow Falls Ahead Of Trump Tariff Decision; Grail Crashes After Test Results (Live Coverage) (Investor's Business Daily)
05:38AM	These Stocks Are Today's Movers: Opendoor, Nvidia, Grail, Newmont, AppLovin, and More (Barrons.com)
05:18AM	Why Grail Stock Is Sinking Friday (Benzinga)
04:57AM	Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers-Grail, Candel Therapeutics, Copart In Focus (Benzinga)
04:06AM	Loading…
04:06AM	Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame. (Barrons.com)
12:00AM	GRAIL Inc (GRAL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Challenges (GuruFocus.com)
Feb-19-26 09:27PM	Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses (Business Wire)
09:10PM	GRAIL Q4 Earnings Call Highlights (MarketBeat)
05:06PM	Grail shares plunge on mixed cancer trial data and steep losses (Investing.com)
04:02PM	GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
04:01PM	Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate (PR Newswire)
08:09AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Analog Devices, Chewy, Credo Technology, eBay, Fiverr, Shopify, Verizon, and More (24/7 Wall St.)
Feb-16-26 09:00AM	GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
Feb-09-26 03:30AM	Hims & Hers Super Bowl Ad For Cancer Test Raises Questions Over Reliability (Benzinga)
Feb-06-26 05:41PM	Hims & Hers Is Offering a New Cancer Test. It May Not Be Ready for Prime Time. (Barrons.com) +6.39%
Feb-04-26 04:09PM	Hims & Hers Scores A Cancer Deal With Grail, But Shares Reverse Lower (Investor's Business Daily) -6.20%
Jan-30-26 01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
Jan-29-26 07:25PM	GRAIL Submits FDA Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test (PR Newswire)
Jan-24-26 12:01PM	The Most Expensive Question Investors Ask (Barchart)
Jan-22-26 03:24PM	Here's Why This Exciting Healthcare Stock Popped 13% Today (Motley Fool) +14.83%
Jan-03-26 10:24AM	Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 (MarketBeat)
Dec-28-25 10:05AM	Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium (Insider Monkey)
Dec-15-25 04:01PM	GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-02-25 04:54AM	Here's Why Grail Soared, Again, in November (Motley Fool)
Dec-01-25 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -10.98%
Nov-20-25 09:41AM	Stocks to Watch Thursday: Walmart, Nvidia, Exact Sciences (The Wall Street Journal)
Nov-19-25 10:38AM	Why GRAIL Stock Could Be Biotech's Next Big Breakout (MarketBeat) +7.99%
Nov-18-25 04:02PM	GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference (PR Newswire)
Nov-17-25 07:30PM	Why Grail Stock Zoomed Nearly 7% Higher on Monday (Motley Fool) +6.67%
Nov-13-25 12:03AM	GRAIL Inc (GRAL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-25 04:02PM	GRAIL Reports Third Quarter 2025 Financial Results (PR Newswire)
09:06AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: AT&T, Beyond Meat, Carvana, Fortinet, Snowflake, Waste Managment and More (24/7 Wall St.)
05:25AM	Cisco Systems headlines earnings slate (MarketWatch)
03:51AM	Stock Market Today: Dow consolidates after 3-day 1,000-point surge to record high, S&P 500 and Nasdaq called higher as Treasury yields dip; Cisco earnings on tap. (MarketWatch)
Nov-06-25 06:00AM	Here's Why Grail Stock Exploded Higher by 55% in October (Motley Fool) -5.41%
Nov-04-25 04:02PM	GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference (PR Newswire) -10.15%
Oct-29-25 04:02PM	GRAIL to Announce Third Quarter 2025 Financial Results (PR Newswire) +6.97%
Oct-25-25 12:45AM	Jim Cramer on GRAIL: "Don't Call Yourself Early if You're Buying This One" (Insider Monkey)
Oct-24-25 08:12AM	Jim Cramer on GRAIL: "I'm Going to Say Absolutely Not to That One" (Insider Monkey) +8.15%
Oct-23-25 09:55AM	Grail Stock Is Up 80% Over the Past Month. Here's Why. (Motley Fool)
Oct-22-25 08:12PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Oct-20-25 04:21PM	Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 31% In A Month (Investor's Business Daily) +17.76% -8.86%
06:30AM	GRAIL, Inc. Announces $325.0 Million Private Placement Financing (PR Newswire)
06:00AM	GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC) (PR Newswire)
Oct-18-25 04:16AM	Grail Blood Test Found Seven Times More Cancers Than Standard Tests, Data Show (Barrons.com)
Oct-17-25 06:08PM	GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings (PR Newswire) -9.73% +17.76%
09:00AM	Precision Oncology Approaches Drive $312B Market Transformation (PR Newswire)
04:21AM	Samsung entities, Grail to roll out early cancer detection test in Asia (Medical Device Network)
Oct-16-25 06:52PM	Why Grail Stock Soared 14% Higher on Thursday (Motley Fool) +14.42%
08:22AM	Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia (PR Newswire)
Sep-26-25 12:46PM	This Cancer Detection Pioneer Is Worth a Look (Motley Fool)
11:25AM	Guardants New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases. (Barrons.com)
Sep-25-25 02:24PM	Guardant's New Blood Test Can Detect Many Different Cancers. It's Promising the Same for Other Diseases. (Barrons.com)
Sep-23-25 09:01AM	GRAIL to Present New Galleri Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC (PR Newswire) +5.62%
Sep-20-25 09:39AM	GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity (Insider Monkey)
Sep-16-25 12:12PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Sep-11-25 05:33PM	More Blood Tests for Cancer Hit the Market (Barrons.com) +9.12%
Sep-10-25 04:02PM	GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum (PR Newswire) -5.62%
Aug-29-25 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Aug-26-25 04:02PM	GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-13-25 03:14AM	GRAIL Inc (GRAL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Aug-12-25 04:02PM	GRAIL Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-11-25 06:55PM	BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
09:06AM	Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 (GlobeNewswire)
Aug-08-25 05:15PM	Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-07-25 07:35PM	Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jul-30-25 04:02PM	GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference (PR Newswire)
Jul-29-25 04:02PM	GRAIL to Announce Second Quarter 2025 Financial Results (PR Newswire) -10.84%
Jul-14-25 11:11AM	GRAIL's Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission (Insider Monkey)
Jul-09-25 07:34AM	Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid 'Equal Weight' Stance (Insider Monkey)
Jun-30-25 04:22PM	Stock Market Today: Dow Jones Up As Apple, Palantir Surge; Robinhood Soars To New Highs On These Moves (Investor's Business Daily) +6.26%
Jun-23-25 12:51PM	Stock Market Today: Dow Jones Reverses, Tesla Surges; These Defense Stocks Gain After Iran Attack (Live Coverage) (Investor's Business Daily) -5.61%
Jun-20-25 09:21AM	With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology (PR Newswire) -5.80%
Jun-19-25 07:05AM	Grail reports positive outcomes from registrational study of Galleri test (Medical Device Network)

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Freidin Aaron	Chief Financial Officer	Apr 08 '26	Sale	49.92	45,806	2,286,526	260,669	Apr 09 06:58 PM
RAGUSA ROBERT P	Chief Executive Officer	Apr 08 '26	Sale	49.92	123,502	6,164,923	518,582	Apr 09 06:58 PM
Ofman Joshua J.	President	Apr 08 '26	Sale	49.92	61,665	3,078,169	371,216	Apr 09 06:58 PM
Aaron Freidin	Officer	Apr 03 '26	Proposed Sale	51.74	49,414	2,556,680		Apr 06 07:50 PM
Joshua Ofman	Officer	Apr 06 '26	Proposed Sale	51.74	66,522	3,441,848		Apr 06 07:49 PM
Robert Ragusa	Officer	Apr 06 '26	Proposed Sale	51.74	133,230	6,893,320		Apr 06 07:47 PM
Freidin Aaron	Chief Financial Officer	Mar 09 '26	Sale	47.89	2,492	119,340	306,475	Mar 09 09:36 PM
Freidin Aaron	Chief Financial Officer	Mar 05 '26	Sale	53.01	655	34,722	308,967	Mar 09 09:36 PM
Ofman Joshua J.	President	Mar 09 '26	Sale	47.89	2,937	140,650	432,881	Mar 09 09:36 PM
Ofman Joshua J.	President	Mar 05 '26	Sale	53.01	690	36,577	435,818	Mar 09 09:36 PM
RAGUSA ROBERT P	Chief Executive Officer	Mar 09 '26	Sale	47.89	7,461	357,296	642,084	Mar 09 09:35 PM
RAGUSA ROBERT P	Chief Executive Officer	Mar 05 '26	Sale	53.01	980	51,950	649,545	Mar 09 09:35 PM
Aaron Freidin	Officer	Mar 04 '26	Proposed Sale	51.80	3,471	179,798		Mar 05 09:12 PM
Robert Ragusa	Officer	Mar 05 '26	Proposed Sale	51.80	9,285	480,963		Mar 05 09:10 PM
Joshua J. Ofman	Officer	Mar 05 '26	Proposed Sale	51.80	3,999	207,148		Mar 05 09:09 PM
Ofman Joshua J.	President	Mar 02 '26	Sale	50.16	17,002	852,848	436,508	Mar 03 09:12 PM
Freidin Aaron	Chief Financial Officer	Mar 02 '26	Sale	50.17	9,573	480,244	309,622	Mar 03 08:45 PM
RAGUSA ROBERT P	Chief Executive Officer	Mar 02 '26	Sale	50.17	37,504	1,881,417	650,525	Mar 03 08:15 PM
Joshua J. Ofman	Officer	Mar 02 '26	Proposed Sale	53.23	18,423	980,656		Mar 02 07:07 PM
Aaron Freidin	Officer	Mar 02 '26	Proposed Sale	53.23	10,374	552,208		Mar 02 07:05 PM
Robert Ragusa	Officer	Mar 02 '26	Proposed Sale	53.23	40,641	2,163,320		Mar 02 06:59 PM
Ofman Joshua J.	President	Dec 03 '25	Sale	100.00	13,000	1,300,000	368,818	Dec 05 04:12 PM
RAGUSA ROBERT P	Chief Executive Officer	Dec 03 '25	Sale	95.24	40,000	3,809,535	688,029	Dec 05 04:12 PM
Freidin Aaron	Chief Financial Officer	Dec 03 '25	Sale	99.15	25,000	2,478,818	259,077	Dec 05 04:12 PM
AARON FREIDIN	Officer	Dec 03 '25	Proposed Sale	99.15	25,000	2,478,818		Dec 03 04:34 PM
JOSHUA J OFMAN	Officer	Dec 03 '25	Proposed Sale	100.00	13,000	1,300,000		Dec 03 04:33 PM
ROBERT P RAGUSA	Officer	Dec 03 '25	Proposed Sale	95.24	40,000	3,809,536		Dec 03 04:31 PM
Freidin Aaron	Chief Financial Officer	Nov 17 '25	Sale	79.20	1,697	134,402	284,077	Nov 19 04:08 PM
ILLUMINA, INC.	10% Owner	Nov 17 '25	Sale	79.85	1,000,000	79,850,000	3,502,126	Nov 18 09:33 PM
Aaron Freidin	Officer	Nov 17 '25	Proposed Sale	79.63	1,940	154,482		Nov 14 06:15 PM
RAGUSA ROBERT P	Chief Executive Officer	Oct 15 '25	Sale	68.88	7,239	498,622	727,388	Oct 16 06:18 PM
Ofman Joshua J.	President	Oct 15 '25	Sale	76.03	8,865	673,985	387,932	Oct 16 06:17 PM
Ofman Joshua J.	President	Oct 16 '25	Sale	82.01	6,114	501,409	381,818	Oct 16 06:17 PM
JOSHUA J OFMAN	Officer	Oct 15 '25	Proposed Sale	69.29	14,979	1,037,895		Oct 15 04:36 PM
Robert Ragusa	Officer	Oct 15 '25	Proposed Sale	69.29	8,275	573,375		Oct 14 06:09 PM
Ofman Joshua J.	President	Oct 06 '25	Sale	62.50	81,385	5,086,562	396,797	Oct 08 04:14 PM
Ofman Joshua J.	President	Oct 02 '25	Sale	64.00	9,692	620,312	478,182	Oct 03 07:01 PM
Joshua Ofman	Officer	Oct 06 '25	Proposed Sale	65.54	89,237	5,848,593		Oct 03 06:56 PM
JOSHUA J OFMAN	Officer	Oct 02 '25	Proposed Sale	62.06	9,692	601,486		Oct 02 04:23 PM
Ofman Joshua J.	President	Aug 19 '25	Sale	32.02	4,202	134,548	487,874	Aug 20 04:24 PM
Freidin Aaron	Chief Financial Officer	Aug 19 '25	Sale	32.02	877	28,082	285,143	Aug 20 04:23 PM
Joshua J. Ofman	Officer	Aug 21 '25	Proposed Sale	32.80	4,511	147,964		Aug 18 08:34 PM
Aaron Freidin	Officer	Aug 21 '25	Proposed Sale	32.43	952	30,873		Aug 15 09:07 PM
Freidin Aaron	Chief Financial Officer	Jul 15 '25	Sale	38.93	8,000	311,440	286,020	Jul 17 05:44 PM
AARON FREIDIN	Officer	Jul 15 '25	Proposed Sale	40.18	8,000	321,440		Jul 15 04:43 PM
DING CHUN R	10% Owner	Jul 01 '25	Sale	49.53	339,800	16,830,151	3,305,055	Jul 03 04:31 PM
Ofman Joshua J.	President	Jun 30 '25	Sale	52.00	9,692	503,984	492,076	Jul 01 04:11 PM
JOSHUA J OFMAN	Officer	Jun 30 '25	Proposed Sale	48.39	9,692	468,996		Jun 30 04:21 PM
Ofman Joshua J.	President	Jun 12 '25	Sale	42.30	9,692	410,019	501,768	Jun 16 04:08 PM
JOSHUA J OFMAN	Officer	Jun 12 '25	Proposed Sale	43.87	9,692	425,188		Jun 12 04:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRAL

GRAIL Inc

Upgrade your Finviz experience